Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine dose comparison during spinal surgery
IRCT20130311012782N53Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of dexmedetomidine in herniated disc (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Blood pressure, Heart rate and 2 more. Started Apr 2021; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
herniated disc
Beyond the preview
Go deeper on IRCT20130311012782N53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130311012782N53.